NewGenIvf Group Limited (NIVF)
NewGenIvf Statistics
Share Statistics
NewGenIvf has 1.7M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 1.7M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 38.5K |
| FTD / Avg. Volume | 0.59% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | 0% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -4.28 and the forward PE ratio is null. NewGenIvf's PEG ratio is 0.01.
| PE Ratio | -4.28 |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | null |
| PB Ratio | 0.19 |
| P/FCF Ratio | -3.19 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NewGenIvf Group Limited.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.07 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.02 |
| Total Debt / Capitalization | 2.09 |
| Cash Flow / Debt | -2.58 |
| Interest Coverage | 0.91 |
Financial Efficiency
Return on equity (ROE) is -0.04% and return on capital (ROIC) is -0.04%.
| Return on Equity (ROE) | -0.04% |
| Return on Assets (ROA) | -0.42% |
| Return on Capital (ROIC) | -0.04% |
| Revenue Per Employee | $73,373.61 |
| Profits Per Employee | $-9,869.3 |
| Employee Count | 70 |
| Asset Turnover | 3.12 |
| Inventory Turnover | 27.36 |
Taxes
| Income Tax | -799.27K |
| Effective Tax Rate | 1.16 |
Stock Price Statistics
The stock price has increased by 101.48% in the last 52 weeks. The beta is -0.3, so NewGenIvf's price volatility has been lower than the market average.
| Beta | -0.3 |
| 52-Week Price Change | 101.48% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 65.74 |
| Average Volume (20 Days) | 6.53M |
Income Statement
In the last 12 months, NewGenIvf had revenue of 5.14M and earned -690.85K in profits. Earnings per share was -0.13.
| Revenue | 5.14M |
| Gross Profit | 1.68M |
| Operating Income | 42.24K |
| Net Income | -690.85K |
| EBITDA | 384.31K |
| EBIT | 42.24K |
| Earnings Per Share (EPS) | -0.13 |
Balance Sheet
The company has 42.22K in cash and 332.55K in debt, giving a net cash position of -290.33K.
| Cash & Cash Equivalents | 42.22K |
| Total Debt | 332.55K |
| Net Cash | -290.33K |
| Retained Earnings | -5.67M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -857.36K and capital expenditures -69.85K, giving a free cash flow of -927.2K.
| Operating Cash Flow | -857.36K |
| Capital Expenditures | -69.85K |
| Free Cash Flow | -927.2K |
| FCF Per Share | -0.17 |
Margins
Gross margin is 32.74%, with operating and profit margins of 0.82% and -13.45%.
| Gross Margin | 32.74% |
| Operating Margin | 0.82% |
| Pretax Margin | -13.45% |
| Profit Margin | -13.45% |
| EBITDA Margin | 7.48% |
| EBIT Margin | 0.82% |
| FCF Margin | -18.05% |
Dividends & Yields
NIVF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -13.68% |
| FCF Yield | -57.41% |
Analyst Forecast
Currently there are no analyst rating for NIVF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Feb 11, 2025. It was a backward split with a ratio of 1:20.
| Last Split Date | Feb 11, 2025 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |